7Baggers
 Anebulo Pharmaceuticals Reports Q1 2026 Financial Results  TipRanks Fri, 14 Nov 2025 05:28:54 GMT
 Anebulo Pharmaceuticals reports Q1 EPS (5c), one estimate (12c)  TipRanks Thu, 13 Nov 2025 22:31:52 GMT
 anebulo pharmaceuticals : earnings release q1 2026  MarketScreener Thu, 13 Nov 2025 21:27:02 GMT
 Anebulo Pharmaceuticals posts Q1 net loss  MarketScreener Thu, 13 Nov 2025 21:25:03 GMT

Anebulo Pharmaceuticals Inc
(NASDAQ:ANEB) 

ANEB stock logo

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction.

Founded: 2020
Founder: Joseph F. Lawler 
CEO: Daniel Schneeberger  
Sector:
Industry:

Share this website to your friends